Cite Filings / SION / 0001315082-26-000002
Feed Companies Filings Check
Sign in
144

Sale of Securities

Sionna Therapeutics, Inc. · Filed 2026-09-17 · Acc 0001315082-26-000002

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-09-18 4 CLO and Head of Program Mgmt. acquired 56,265 shares (grant or award)
  • 2026-09-18 4 CMO and Head of R&D acquired 100,000 shares (grant or award)
  • 2026-09-18 4 CFO and CBO acquired 94,537 shares (grant or award)
  • 2026-09-18 4 President & CEO acquired 218,050 shares (grant or award)
  • 2026-09-17 144 Sale of Securities
  • 2026-09-14 8-K Exit or restructuring costs · Executive or director change · Other events
  • 2026-07-06 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…